Effectiveness of Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva): First Experience

Breast and prostate cancer have a propensity to metastasize to bones and cause osteolysis and abnormal new bone formation. Metastases locally disrupt normal bone remodeling. Although metastases from prostate cancer have been classified as osteoblastic based on the radiographic appearance of the lesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasulova, Nigora, Lyubshin, Vladimir, Arybzhanov, Dauranbek, Krylov, Valery, Khodjibekov, Marat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745628/
https://www.ncbi.nlm.nih.gov/pubmed/23961251
http://dx.doi.org/10.4103/1450-1147.113942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745628/
https://www.ncbi.nlm.nih.gov/pubmed/23961251
http://dx.doi.org/10.4103/1450-1147.113942

Ejemplares similares